In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
386 News Items found
Attendees of the fifth annual MSK-CTONG Symposium
Memorial Sloan Kettering and the Chinese Thoracic Oncology Group Urge International Harmonization to Accelerate Cancer Drug Approvals at Annual Event

Global regulatory harmonization of clinical trials provides significant opportunity to accelerate access to cancer treatments to benefit all of humanity. This was the theme of the fifth annual MSK-CTONG Symposium, hosted online for a global audience of 20,000 from Guangzhou, China and New York on December 2, 2022.
MSK physician-scientist Yu Chen
MSK Scientists Identify New — and Very Common — Subtype of Prostate Cancer

The findings could pave the way toward more targeted treatments for the disease.
Proximal tubule of the kidney.
In the Lab
Miniature Device Could Unlock the Promise of Some Kidney Cancer Drugs

Memorial Sloan Kettering scientists have engineered a tiny particle that could ferry drugs directly to the kidneys and prevent their uptake in other organs.
Research Suggests Potential Immune Therapy for Preventing Breast Cancer Metastasis

A new therapy tested in mouse models appears to harness neutrophils, a type of white blood cell, to effectively prevent the spread of breast cancer cells.
MSK surgeons are highly skilled at treating even the most difficult gynecologic cancers.
In the Clinic
5 Reasons MSK Excels at Treating Gynecologic Cancers

Read why MSK’s medical team is the best in the nation at treating gynecologic cancers.
Image of As, Ts, Cs, and Gs representing genetic code
Announcement
AACR Project GENIE Seeks to Advance Cancer Treatment

Eight leading cancer centers are coming together to share genomic sequencing data, in the hope of making faster progress in curing cancer.
Image of DNA helix with sequence in the background
In the Clinic
Genetic ‘Scars’ Provide Clues for Tailoring Cancer Treatment

For the first time, scientists have determined the extent of DNA repair deficiencies across cancer types. Learn what it means for patients.
A researcher working in an MSK lab
MSK Research Highlights, October 31, 2025

New MSK research uncovers unique genetic signatures in cancer patients of non-European ancestry; identifies social adversity as a potential risk factor for higher rates of triple-negative breast cancer among Black women; shows a web-based system could help head-and-neck cancer survivors report their concerns; and finds adding immunotherapy can boost the effectiveness for hard-to-treat follicular lymphomas.
Direna Alonso Curbelo
Sloan Kettering Institute Scientists Learn How Genes and Environment Conspire in Pancreatic Cancer Development

The insights lay the groundwork for earlier diagnosis and better treatment of the disease.
Scientific Image
In the Clinic
CAR Therapy for Solid Tumors Draws Attention at Annual Cancer Conference

Results from a clinical trial indicate that an experimental CAR therapy for mesothelioma is safe.